Atara announces q3 2019 financial results

Atara biotherapeutics announces third quarter 2019 financial results and recent clinical, operational and strategic progress.cash, cash equivalents and short-term investments as of september 30, 2019 totaled $282.9 million.qtrly loss per share $1.31 per share.q3 earnings per share view $-1.44, revenue view $0.00 -- refinitiv ibes data.

ATRA Ratings Summary

ATRA Quant Ranking